Search

Your search keyword '"positive and negative syndrome scale"' showing total 4,567 results

Search Constraints

Start Over You searched for: Descriptor "positive and negative syndrome scale" Remove constraint Descriptor: "positive and negative syndrome scale"
4,567 results on '"positive and negative syndrome scale"'

Search Results

2. Prevalence and risk factors for chronic kidney disease among older adult patients with schizophrenia in Taiwan.

3. Longitudinal evaluation of the early auditory gamma-band response and its modulation by attention in first-episode psychosis.

4. Cognitive impairment in the schizophrenia spectrum: exploring the relationships of the g-factor with sociodemography, psychopathology, neurodevelopment, and genetics.

5. Predictors of clozapine efficacy in treatment-resistant schizophrenia: A cross-sectional analysis of sociodemographic, clinical, biochemical, and electrophysiological EEG changes

6. Resting-state electroencephalogram in drug-free subjects with at-risk mental states who later developed psychosis: a low-resolution electromagnetic tomography analysis.

7. Influence of perceived harm due to substance use on the relationships between positive psychotic experiences and suicidal experiences in people with non-affective psychosis.

8. Predictors of clozapine efficacy in treatment-resistant schizophrenia: A cross-sectional analysis of sociodemographic, clinical, biochemical, and electrophysiological EEG changes.

9. Efficacy of HP-3070, A Once-Daily Asenapine Transdermal System, in the Treatment of Adults with Schizophrenia: A PANSS Five-Factor Analysis

10. The effectiveness of risperidone on PANSS score and IL-6 in confirmed COVID-19 schizophrenic patients

11. The European Portuguese Version of the Brief Negative Symptom Scale.

12. 不同首发年龄精神分裂症患者 临床特征及影响.

13. How first-episode psychosis patients' subjective beliefs about their childhood trauma's causal effect provide support for potential schizophrenia subtypes.

14. The efficacy and safety of sodium nitroprusside in the treatment of schizophrenia: a meta-analysis.

15. Effects of Brexpiprazole Across Symptom Domains in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies

16. Comparative Assessment of Effect on Psychomotor Performance Efficacy and Adherence of Levosulpiride and Olanzapine in Patients with Schizophrenia: A Parallel, Open-label, Prospective Observational Study.

17. Association of CTNND2 gene polymorphism with schizophrenia: Two-sample case-control study in Chinese Han population.

18. The Arabic Questionnaire for Psychotic Experiences in patients with psychotic disorders: a clinical validation

19. Do symptoms moderate the association between participation and executive functions outcomes among people with schizophrenia?

20. Efficacy of clozapine in patients with schizophrenia – A 3-month follow-up study from North India

21. Efficacy of Clozapine in Patients with Schizophrenia - A 3-Month follow-up Study from North India.

22. Positive and general psychopathology associated with specific gray matter reductions in inferior temporal regions in patients with schizophrenia.

23. The Arabic Questionnaire for Psychotic Experiences in patients with psychotic disorders: a clinical validation.

24. Association of reduced cortical thickness and psychopathological symptoms in patients with first-episode drug-naïve schizophrenia.

25. Obsessive-compulsive symptoms in patient with schizophrenia: The influence of disorganized symptoms, duration of schizophrenia, and drug resistance.

26. Participant Engagement and Symptom Improvement: Aripiprazole Tablets with Sensor for the Treatment of Schizophrenia

27. Do symptoms moderate the association between participation and executive functions outcomes among people with schizophrenia?

28. Recognition of facial emotion expressions and perceptual processes in 22q11.2 deletion syndrome.

29. Assessment Of Caregivers' burden Of Patients With Schizophrenia And Bipolar Disorder.

30. Optical coherence tomography in Egyptian schizophrenics and its correlation to disease parameters

31. Dissociation between neuroanatomical and symptomatic subtypes in schizophrenia

32. Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium

33. Longitudinal invariance of the positive and negative syndrome scale negative dimension in antipsychotic naïve first‐episode schizophrenia.

34. Role of Cariprazine in First Episode Psychosis.

35. Cognitive deficits in familial schizophrenia

36. Lurasidone switching in patients with schizophrenia who showed suboptimal effect and/or intolerability to current antipsychotics: A multi-center, open-label, single-arm, flexible dose study

37. Psychosocial functioning as a personal resource promoting a milder course of schizophrenia.

38. Schizophrenia and toxoplasmosis: association with catatonic symptoms

39. Resting-state electroencephalogram in drug-free subjects with at-risk mental states who later developed psychosis: a low-resolution electromagnetic tomography analysis.

40. Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms

41. Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study.

42. Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms.

43. 精神分裂症患者临床特征及相关影响因素.

44. Systemic lupus erythematosus and autoimmune features in chronic hospitalized patients with schizophrenia.

45. Decreased serum S100A10 levels in patients with both schizophrenia and metabolic syndrome

46. Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial

47. Effect of Memantine on Positive Sign in Patients with Schizophrenia and Schizoaffective Disorders: A Randomized Double Blind Placebo Controlled Trial

48. Association Between Abundance of Haemophilus in the Gut Microbiota and Negative Symptoms of Schizophrenia

49. Reduced Cell-Free Mitochondrial DNA Levels Were Induced by Antipsychotics Treatment in First-Episode Patients With Schizophrenia

50. Assessment of the Minimum Clinically Important Difference in Symptoms and Functions of Patients With Acute Schizophrenia: A Post hoc Analysis of an Open-Label, Single-Arm Multicenter Study

Catalog

Books, media, physical & digital resources